Streetbeat News

Stock Prices

PENN

Needham analyst Bernie McTernan has reiterated a Buy rating on PENN Entertainment (NASDAQ:PENN) and maintained a $33 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 3:38 pm

CYTO

Altamira Therapeutics Ltd (NASDAQ:CYTO) stock plummeted by 50% to $0.20 after announcing strategic changes, including a partial spin-off of its Bentrio business and a 20-for-1 reverse stock split scheduled for December 13. The company sold a 51% stake in Altamira Medica AG for approximately $2.3 million, retaining Bentrio, a key asset with expected sales growth from 2024. Altamira is also seeking partnerships for its inner ear therapeutics, particularly AM-125, which is in Phase 2 trials.

Portfolio Pulse from Henry Khederian

December 11, 2023 | 3:35 pm

SHAK

Shake Shack Inc (NYSE:SHAK) CEO Randy Garutti announced his intention to retire in 2024 after a successor is chosen. He will remain CEO and an executive Board member until then and will serve as an advisor through the end of 2024. The Board has initiated an external search for a new CEO. Shake Shack reiterated its Q4 revenue outlook of $276.25 million to $281.75 million and FY23 revenue of $1.08 billion, with expectations of low-single digits Same-Shack sales growth and a Shack-level operating profit margin of approximately 19.0%. The company also plans 40 new domestic and 40 licensed openings. SHAK shares rose 7.22% to $65.38.

Portfolio Pulse from Shivani Kumaresan

December 11, 2023 | 3:34 pm

PARA

Paramount Global's stock (PARA) trades lower following a downgrade from Hold to Sell by Loop Capital, which also set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 3:31 pm

HON

Over the past 15 years, Honeywell Intl (NASDAQ:HON) has produced an average annual return of 13.16%, outperforming the market. A $100 investment in HON stock 15 years ago would be worth $680.95 today. Honeywell Intl currently has a market cap of $129.66 billion. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 3:30 pm

HES

Over the past 5 years, Hess Corporation (NYSE: HES) has delivered an average annual return of 21.66%, outperforming the market by 9.59% on an annualized basis. A $1000 investment in HES stock five years ago would be worth $2,610.85 today. Hess currently has a market capitalization of $41.67 billion.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 3:30 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trade strategies for SPY, QQQ, AAPL, MSFT, NVDA, TSLA, GOOGL, and META, based on a proprietary formula involving price, volume, and options flow. The memo outlines potential bullish and bearish price levels for each asset and advises traders to monitor these stocks closely for breakouts or reversals. The focus is on large funds positioning ahead of the upcoming FOMC rate decision, with a light data schedule for the day. The memo is part of the Market Clubhouse community offerings, which include live daily market analysis, a watch list, and real-time mentorship from a pro trader known as RIPS.

Portfolio Pulse from RIPS

December 11, 2023 | 3:27 pm

CUEN

Cuentas, Inc. has enabled shareholders to cast proxy votes before the Annual Meeting on December 20, 2023. The company has filed a Definitive Proxy Statement for electing directors and ratifying its accounting firm. Cuentas has launched an electronic voting platform and distributed printed materials to facilitate this process. CEO Arik Maimon expressed satisfaction with the company's 2023 performance, expansion in various sectors, and remains optimistic about the share price reflecting the company's execution. Shareholders are encouraged to vote online or by mail.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 3:25 pm

CYTO

Altamira Therapeutics shares are down following the announcement of a 20-for-1 reverse stock split decided by its Board of Directors, to be effected on December 13, 2023.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 3:23 pm

COGT

CYTO

HUM

IONM

KTTA

NIR

NXTP

U.S. stocks were mixed with the Dow Jones slightly up and NASDAQ and S&P 500 down. Cigna (CI) shares rose after ending acquisition talks with Humana (HUM) due to price disagreements. Pasithea Therapeutics (KTTA), Assure Holdings (IONM), and NextPlay Technologies (NXTP) saw significant gains, while Cogent Biosciences (COGT), Altamira Therapeutics (CYTO), and Near Intelligence (NIR) experienced sharp declines. No major US economic releases were reported.

Portfolio Pulse from Avi Kapoor

December 11, 2023 | 3:20 pm